NCT03010514

Brief Summary

This is a national registry study to determine genetic risk factor and serial biomarkers of thoracic aortic aneurysm/dissection

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 5, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

January 5, 2017

Status Verified

January 1, 2017

Enrollment Period

2.5 years

First QC Date

December 21, 2016

Last Update Submit

January 3, 2017

Conditions

Outcome Measures

Primary Outcomes (23)

  • Age for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Gender for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Height for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Weight for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Contact information for each participant

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Past Medical History including disease history, surgical history, and family medical history

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Lifestyle including smoking history and drinking, specify how many years smoking or drinking lasted and detail quantity per day

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Exon sequencing data of each participant

    Sequencing will be carried out in an average of 3 months after sample recruiting

  • Serum biomarker screening data of each participant

    Screening will be carried out in an average of 3 months after sample recruiting

  • The location of Aneurysm/Dissection

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • The size of Aneurysm/Dissection

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • blood biochemical index:blood lipid

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • blood biochemical index:blood glucose

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • blood biochemical index:uric acid

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • blood biochemical index:urea

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • blood biochemical index:creatinine

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • blood biochemical index:C reactive protein

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • blood biochemical index:d dime

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Drug treatment

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Surgery type

    These data is collected from the cases' medical record in an average of 1 month after the sample recruiting

  • Prognosis information: all-cause death

    These data is collected during follow-up visit at 3/6/12 months after discharge

  • Prognosis information: whether recidivation happened

    These data is collected during follow-up visit at 3/6/12 months after discharge

  • Prognosis information including: whether other related disease happened

    These data is collected during follow-up visit at 3/6/12 months after discharge

Study Arms (2)

case

control

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

case group consists of patients who was diagnosed as thoracic aortic aneurysm/dissection; control group is general population without aortic aneurysm/dissection

You may qualify if:

  • Subject who was diagnosed as thoracic aortic aneurysm/dissection by CT angiography, interventional angiography or vascular ultrasound;
  • Age is less than 80 years old;
  • male and non pregnancy female;
  • Subject understands study requirements aand agrees to sign an informed consent form prior to any study procedures.

You may not qualify if:

  • Subject has one of the following:
  • Pseudoaneurysm;
  • Previous infection or trauma in the damaged part of aorta;
  • Pregnancy female;
  • Participate in other clinical trials in the last 1 months.
  • Age and gender are matched with cases;
  • No aortic disease was detected by outpatient ultrasound;
  • No family history of cardiovascular disease;
  • Normal biochemical indicators;
  • Criteria for culling, shedding and suspension testing:
  • Culling: Unqualified cases and controls. Data of culled subjects can not be used for statistical analysis;
  • Shedding: Subject that self withdrawal, loss to follow-up, or quitted by doctors; Reasons for shedding should be indicated for each shed subject.
  • Suspension: a) The researchers found significant safety problems or wrong study design; b) Researchers cannot continue clinical research due to funding or management reasons; c) Director ends the study. When suspension happens, all the CRF table should be reserved for future reference.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Anzhen Hospital

Beijing, 100029, China

RECRUITING

Related Publications (1)

  • Fang G, Tian Y, Huang S, Zhang X, Liu Y, Li Y, Du J, Gao S. KLF15 maintains contractile phenotype of vascular smooth muscle cells and prevents thoracic aortic dissection by interacting with MRTFB. J Biol Chem. 2024 May;300(5):107260. doi: 10.1016/j.jbc.2024.107260. Epub 2024 Apr 4.

Biospecimen

Retention: SAMPLES WITH DNA

If a blood specimen is obtained, it will be separated and stored at -80 ℃ as plasma, viable cells, and extracted DNA. If a saliva specimen is obtained, it is stored for DNA. If a tissue specimen is obtained, it will be cut into small pieces and stored at liquid nitrogen.

MeSH Terms

Conditions

Aortic Aneurysm, ThoracicAortic Dissection

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic DiseasesDissection, Blood VesselAcute Aortic Syndrome

Study Officials

  • Jie Du, PHD

    Beijing Anzhen Hospital

    STUDY DIRECTOR

Central Study Contacts

Yulin Li, PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2016

First Posted

January 5, 2017

Study Start

October 1, 2016

Primary Completion

April 1, 2019

Study Completion

October 1, 2019

Last Updated

January 5, 2017

Record last verified: 2017-01

Locations